This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Colorectal Cancer Metastatic or Skin Toxicity
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

The aim of this study is to test the role of cycline in the prevention of acne-like skin rash in metastatic colorectal patients treated with Cetuximab and intensified FOLFIRI.

Provided treatments

  • Drug: Doxycycline
  • Drug: Cetuximab

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01317433. The sponsor of the trial is Institut Cancerologie de l'Ouest and it is looking for 25 volunteers for the current phase.
Official trial title:
Pre-emptive Cycline Treatment on Cetuximab-induced Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With an Intensified FOLFIRI.